Biosource Technologies, Inc. Adopted the Name of Its Acquired Subsidiary, Large Scale Biology Corporation.

VACAVILLE, Calif.--(BW HealthWire)--Nov. 8, 1999--

Biosource Technologies, Inc. announced today that it has adopted the name of its acquired subsidiary, Large Scale Biology Corporation (Rockville, MD). All divisions of the company, Genomics, Antigenics, Proteomics and Bioprocessing, will now fall under the new corporate name and logo of Large Scale Biology Corporation.

Privately held Biosource Technologies, founded in 1987, acquired Large Scale Biology in February of this year. Its acquisition established the joint company as a leader in protein-focused technologies, providing the life sciences industry with tools for defining complex biological processes at the functional level. Large Scale Biology's approach to high-throughput functional genomics, proteomics, informatics and large-scale production of therapeutic polypeptides forms an integrated life sciences technology platform. By building this strong core of functionally-based protein technologies, Large Scale Biology Corporation is now positioned to play a key role in the development of personalized health care.

"I am confident that history will record the merger of our two companies as one of the seminal events in the development of the biological sciences and medical arts," stated Bob Erwin, CEO of Large Scale Biology Corporation. "Our new name reflects the significance of our undertaking."

"In the process of developing the synergies between our various protein technologies, it became clear that what we're doing really is `Large Scale Biology' - large numbers of proteins, large numbers of samples, large amounts of protein product", commented Dr. Leigh Anderson, CEO of LSB's proteomics subsidiary. "We're pleased to have been able to contribute a name that both explains what we do, and indicates where we're headed."

Large Scale Biology Corporation is a fully integrated research-through-manufacturing enterprise that provides novel protein-focused technologies to greatly improve the speed and productivity of life sciences discovery and product development programs. Corporate offices and the Genomics and Antigenics divisions are headquartered in Vacaville, California. The Proteomics division, originally founded as Large Scale Biology Corporation, is the leading provider of proteomic technologies to the life sciences industry, and is located in Rockville, Maryland. Large Scale Biology's Bioprocessing and manufacturing facilities are located in Owensboro, Kentucky. For more information about Large Scale Biology, visit its two websites at www.biosource-technologies.com and www.lsbc.com, both of which will be maintained until fully integrated.